Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CVRx (CVRX)
NASDAQ:CVRX
Holding CVRX?
Track your performance easily
CVRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$6.40 - $29.23
Previous CloseN/A
Volume20.10K
Average Volume (3M)193.94K
Market Cap
$419.76M
Enterprise Value$151.00M
Total Cash (Recent Filing)$25.74M
Total Debt (Recent Filing)$18.99M
Price to Earnings (P/E)―
Beta2.32
Next Earnings
Jan 23, 2025EPS Estimate
-0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.71
Shares Outstanding24,263,662
10 Day Avg. Volume268,872
30 Day Avg. Volume193,940
Standard Deviation0.28
R-Squared0.04
Alpha0.00774
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)8.88
Price to Cash Flow (P/CF)-10.10
P/FCF Ratio0.00
Enterprise Value/Market Cap0.36
Enterprise Value/Revenue3.20
Enterprise Value/Gross Profit4.57
Enterprise Value/Ebitda-2.69
Forecast
1Y Price Target
$18.60Price Target Upside5.56% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
CVRx News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceCVRX reported Q3/24 revenue of $13.4M, which was ahead of estimates and consensus.
Market OpportunityCVRx’s Barostim fulfills a clinical unmet need in an unpenetrated $2.2B annual incidence market.
Reimbursement StabilityFinal OPPS rule indicates CVRX’s reimbursement will remain as previously assigned, a win for the company.
Bears Say
Financial PerformanceEPS was lower than both analyst and street estimates, driven by higher compensation and headcount expenses.
Reimbursement UncertaintyThere is a possibility that CMS may move CVRx to a level 5 neurostimulator code, potentially decreasing Barostim’s reimbursement from $45K to ~$31.2K.
Revenue ExpectationsThe company lowered its 2025 revenue estimates based on management commentary.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CVRX FAQ
What was CVRx’s price range in the past 12 months?
CVRx lowest stock price was $6.40 and its highest was $29.23 in the past 12 months.
What is CVRx’s market cap?
CVRx’s market cap is $419.76M.
When is CVRx’s upcoming earnings report date?
CVRx’s upcoming earnings report date is Jan 23, 2025 which is in 5 days.
How were CVRx’s earnings last quarter?
CVRx released its earnings results on Oct 29, 2024. The company reported -$0.57 earnings per share for the quarter, missing the consensus estimate of -$0.504 by -$0.066.
Is CVRx overvalued?
According to Wall Street analysts CVRx’s price is currently Undervalued.
Does CVRx pay dividends?
CVRx does not currently pay dividends.
What is CVRx’s EPS estimate?
CVRx’s EPS estimate is -0.37.
How many shares outstanding does CVRx have?
CVRx has 24,263,662 shares outstanding.
What happened to CVRx’s price movement after its last earnings report?
CVRx reported an EPS of -$0.57 in its last earnings report, missing expectations of -$0.504. Following the earnings report the stock price went up 31.006%.
Which hedge fund is a major shareholder of CVRx?
Among the largest hedge funds holding CVRx’s share is Mairs & Power Inc. It holds CVRx’s shares valued at 1M.
---
CVRx Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$18.60 (5.56% Upside)
$18.60 (5.56% Upside)
Blogger Sentiment
Neutral
CVRX Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 4.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $19.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 14.5%
Last 30 Days ▲ 14.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-36.75%
12-Months-Change
Fundamentals
Return on Equity
-79.02%
Trailing 12-Months
Asset Growth
19.99%
Trailing 12-Months
Company Description
CVRx
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases.
---
CVRX Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and significant reimbursement wins, particularly in the U.S. market, alongside expansion in implanting centers and a robust cash position. However, challenges included increased operating expenses and a rise in net loss and interest expenses. The company remains optimistic about future growth and adoption of its Barostim therapy.Read More>---
CVRX Stock 12 Month Forecast
Average Price Target
$18.60
▲(5.56% Upside)
Technical Analysis
Best Analysts Covering CVRX
1 Year
1 Year Success Rate
10/15 ratings generated profit
1 Year Average Return
+24.57%
reiterated a buy rating 6 days ago
Copying William Plovanic's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +24.57% per trade.
---